Evaluating the potential of chelation therapy to prevent and treat gadolinium deposition from MRI contrast agents

Several MRI contrast agent clinical formulations are now known to leave deposits of the heavy metal gadolinium in the brain, bones, and other organs of patients. This persistent biological accumulation of gadolinium has been recently recognized as a deleterious outcome in patients administered Gd-ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Rees, Julian A., Deblonde, Gauthier J.-P., An, Dahlia D., Ansoborlo, Camille, Gauny, Stacey S., Abergel, Rebecca J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849765/
https://www.ncbi.nlm.nih.gov/pubmed/29535330
http://dx.doi.org/10.1038/s41598-018-22511-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5849765/
https://www.ncbi.nlm.nih.gov/pubmed/29535330
http://dx.doi.org/10.1038/s41598-018-22511-6

Ejemplares similares